Professor Anthony Wierzbicki is consultant in metabolic medicine/chemical pathology at Guy’s & St. Thomas’ Hospitals and honorary Professor in Cardiometabolic Disease at King’s College, London. He runs a regional centre for lipid disorders . He is clinical lead for Blood Sciences . His research interests are in the role of lipids in atherosclerosis and in peroxisomal diseases. He is a Fellow of the American Heart Association and the National Academy of Clinical Biochemistry (USA). He has published 350 papers, 19 book chapters and 1 book. He was a trustee of HEART-UK (UK Cholesterol charity) and chairman of its medical and scientific committee (2002-08).
He helped write the International guidelines on Familial Hypercholesterolaemia (2014) and the American Heart Association scientific consensus statement on Familial Hypercholesterolemia (2015). At the National Institute for Health and Clinical Excellence (NICE) he has served on the Technology Appraisal (2006-9), Highly Specialised (orphan disease) Therapies (2013-5) and Diagnostics Appraisal committees (2014-20). He was a member of the Familial Hypercholesterolaemia guideline group (CG71; 2008-2009) and chair of the Lipid Modification (CG181; 2012-4); Chronic Heart Failure (NG106; 2016-18), Hypertension (NG136 2017-20) and Chronic Kidney Disease (2020-22).
